Oncology Clinical Trials in Hartford, CT

As of June 2026, 55 paid clinical trials are recruiting for Oncology in Hartford, Connecticut. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

55 clinical trials for Oncology

·Clear filters·↓ Download CSV

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for Acute Myeloid Leukemia

185 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT04293562·Phase 3·Recruiting

Apply to this trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

for Lung Non-Small Cell Carcinoma

1150 locations incl. Anchorage

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04267848·Phase 3·Recruiting

Apply to this trial

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

for Endometrial Cancer

13 locations incl. Hartford

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18+

Code: NCT04291612·Recruiting

Apply to this trial

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

for Rectal Adenocarcinoma

10 locations incl. Hartford

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT04165772·Phase 2·Recruiting

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

203 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting

Apply to this trial

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

for Triple Negative Breast Cancer

12 locations incl. San Carlos

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT03808337·Phase 2·Recruiting

Apply to this trial

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for Head and Neck Carcinoma

14 locations incl. Santa Rosa

Sponsor: VM Oncology, LLC

Sex: All·Age: 18 - 80

Code: NCT03556228·Phase 1, Phase 2·Recruiting

Apply to this trial

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for Ganglioneuroblastoma

152 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 30

Code: NCT03126916·Phase 3·Recruiting

Apply to this trial

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for Cancer, Metastatic

67 locations incl. Birmingham

Sponsor: Massive Bio, Inc.

Sex: All·Age: All ages

Code: NCT03452774·Recruiting

Apply to this trial

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for Lymphoma, Non-Hodgkin

174 locations incl. Birmingham

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 12+

Code: NCT02693535·Phase 2·Recruiting

Apply to this trial

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

for Acute Leukemia

3 locations incl. Hartford

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18 - 80

Code: NCT02677064·Recruiting

Apply to this trial

Neuroblastoma Maintenance Therapy Trial

for Neuroblastoma

42 locations incl. Birmingham

Sponsor: Giselle Sholler

Sex: All·Age: 1 - 30

Code: NCT02679144·Phase 2·Recruiting

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

245 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting

Apply to this trial

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for Neuroblastoma

24 locations incl. Birmingham

Sponsor: Giselle Sholler

Sex: All·Age: Up to 22

Code: NCT02559778·Phase 2·Recruiting

Apply to this trial

Genomic Profiling in Cancer Patients

for Solid Tumors

18 locations incl. Bridgeport

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: All ages

Code: NCT01775072·Recruiting

Apply to this trial

Conditions in Oncology (Hartford, CT)

Non-small cell lung cancer (NSCLC)· 9 Neuroblastoma· 9 Solid tumor· 8 Breast cancer· 7 Leukemia (other)· 5 Metastatic breast cancer· 3 Prostate cancer· 3 Ovarian cancer· 3 Myelodysplastic syndromes (MDS)· 3 Lung cancer· 2 Pancreatic cancer· 2 Biliary tract cancer· 2 Endometrial cancer· 2 Acute myeloid leukemia (AML)· 2 Myeloproliferative neoplasm· 2 Non-Hodgkin lymphoma· 2 Mantle cell lymphoma· 2 Melanoma· 2 Osteosarcoma· 2 Pediatric cancer· 2 Cancer (any)· 2 Triple-negative breast cancer· 1 HER2-positive breast cancer· 1 Esophageal cancer· 1 Liver cancer· 1 Gastrointestinal cancer· 1 Bladder cancer· 1 Kidney cancer· 1 Cervical cancer· 1 Gynecologic cancer· 1 Glioblastoma· 1 Glioma· 1 Multiple myeloma· 1 Acute lymphoblastic leukemia· 1 Myelofibrosis· 1 Follicular lymphoma· 1 Marginal zone lymphoma· 1 Hematologic malignancy· 1 Head and neck cancer· 1 Ewing sarcoma· 1 Mesothelioma· 1 Neuroendocrine tumors· 1